Who Paid My Doc
ArmonAir Digihaler
Drug Respiratory
NDC 59310-114-06
General payments
$614,421
Research payments
$800,192
Through program year 2025, $614,421 in general payments and $800,192 in research payments were reported against ArmonAir Digihaler (Respiratory).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $370 | 6 |
| 2025 | Research | $34,563 | 206 |
| 2024 | General | $2,997 | 7 |
| 2024 | Research | $765,629 | 45 |
| 2023 | General | $23,347 | 108 |
| 2022 | General | $744 | 37 |
| 2021 | General | $586,724 | 1,612 |
| 2020 | General | $239 | 15 |
Breakdown
The top 5 of 6 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
1,785 general · 251 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.